All Articles
FDA Diversity Action Plan in 2026: Is a Diversity Action Plan Still Required for Clinical Trials?
The Diversity Action Plan requirement has been the most talked-about, least enforced piece...
Deeksha Gitta
Signs of stroke in women: how to recognize them and what to do
Signs of stroke in women can look different from what most people expect. Stroke is one of...
Anish Teepireddy
Direct-to-patient shipping in clinical trials: how study medication arrives safely at home
Home delivery of prescription medications has become a familiar part of everyday healthcar...
Swaroop ESDParticipants
Signs of stroke in women: how to recognize them and what to do
Signs of stroke in women can look different from what most people expect. Stroke is one of...
Anish TeepireddyDirect-to-patient shipping in clinical trials: how study medication arrives safely at home
Home delivery of prescription medications has become a familiar part of everyday healthcar...
Swaroop ESD
Women’s Equality Day: what does August 26 commemorate, and why does it still matter?
Every August 26, the United States marks Women’s Equality Day. The observance honors a sin...
ParamrajSponsors
FDA Diversity Action Plan in 2026: Is a Diversity Action Plan Still Required for Clinical Trials?
The Diversity Action Plan requirement has been the most talked-about, least enforced piece...
Deeksha Gitta
Patient tokenization in clinical trials: How sponsors link trial data to real-world outcomes
Real-world data has moved from a supporting cast in clinical development to a central char...
Paramraj
Risk-based quality management under ICH E6(R3): what sponsors need to understand
Clinical trial quality used to sit in a section. Under ICH E6(R3), it sits in the spine. T...
Deeksha GittaResearch Sites
Health Unit Coordinator Day: the behind-the-scenes team that helps clinical trials run
Every August 23, the United States recognizes Health Unit Coordinator Day. The date honors...
Paramraj
Site oversight of home nursing and mobile phlebotomy in decentralized trials
Home nursing visits and mobile phlebotomy have moved from pandemic-era experiments to rout...
Mahesh Upadrista
Hybrid clinical trial visits: how research sites decide what stays on-site and what goes remote
Hybrid designs are no longer an experiment for research sites to accommodate on the margin...
Vamshi KantojuCROs
How CROs use predictive feasibility modeling to select clinical trial sites
Predictive feasibility modeling has moved from a data science experiment to an increasingl...
Anish Teepireddy
Direct-to-Patient Drug Shipments at Clinical Trial Sites: What Are They and How Do Sites Stay Compliant?
Direct-to-patient shipment moves the study drug from the research site to the participant'...
Swaroop ESD
Building external control arms: how CROs source data and clear regulatory review
External control arms have moved from a niche design tool to a recurring conversation betw...
Swaroop ESDHealthcare Professionals (HCPs)
Digital Endpoints in Clinical Trials: How HCPs Interpret Wearable Data From Their Patients
Wearable devices now generate a substantial share of the data collected during modern clin...
Deeksha Gitta
Point-of-care clinical trials: how research fits inside routine practice
Clinical research and clinical care have long operated as parallel systems. Patients recei...
Anish Teepireddy
How to read a master protocol as a referring physician
A patient sits across from you with newly diagnosed advanced non-small cell lung cancer. H...
ParamrajAdvocacy Groups
Tokenization in Clinical Trials: What Should Advocacy Groups Ask Sponsors About Patient Privacy
Tokenization has become one of the most widely adopted data techniques in modern clinical ...
Mahesh Upadrista
How advocacy groups turn patient registries into clinical trials
For most rare and chronic disease communities, the biggest obstacle to research is not sci...
Deeksha Gitta
The Diversity Action Plan debate, explained for advocacy groups
A federal rule that was supposed to make clinical trials more representative of the people...
Swaroop ESD